Clinical Trials Browser

Small Cell Lung Carcinoma × Cyclophosphamide × 90 days × Clear all

NCT07509034 2026-06-05

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease

Phase 1 Not yet recruiting

Recurrence, Small Cell Lung Carcinoma